Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 4Carcinoma, Non-Small-Cell Lung 3Recurrence 2Pleural Effusion, Malignant 2Mesothelioma, Malignant 2Uveal Melanoma 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Pancreatic Neoplasms 1Neuroblastoma 1Neoplasms, Plasma Cell 1Neoplasms 1NSCLC 1Myeloproliferative Disorders 1Multiple Myeloma 1Melanoma 1Lymphoma 1Lymphedema 1Leukemia, Myeloid, Chronic-Phase 1Immunoglobulin Light-chain Amyloidosis 1Hereditary Sensory and Autonomic Neuropathies 1Head and Neck Neoplasms 1Glioblastoma 1Fibrosis 1Fallopian Tube Neoplasms 1Dysplastic Nevus Syndrome 1Colorectal Neoplasms 1Cholangiocarcinoma 1

Interventions

Pharmaceutical Preparations 1Irinotecan 1Fluorouracil 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
BRAF V600 Colorectal Cancer × Pharmaceutical Preparations × 1 year × Clear all
NCT07150247 2025-09-26

Safety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal Cancer

Sun Yat-sen University

Phase 2 Recruiting
20 enrolled
Gastrointestinal

BRAF V600 Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡